关节镜器材市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球关节镜器材市场规模达65亿美元，预计2034年将以3.9%的复合年增长率成长，达到94亿美元。关节相关疾病发生率上升、老龄人口增长以及运动伤害增加是推动该市场发展的主要因素。目前，人们越来越倾向于微创手术，而关节镜检查因其恢復时间短、住院时间短、术后併发症少等优势，成为首选方法。此外，视觉化技术、机器人整合以及对一次性器械的重视正在改变关节镜检查程序。患者对关节问题早期治疗和诊断的认识不断提高，也有助于刺激全球对这些器材的需求。

门诊手术中心（尤其是在城市地区）正在迅速扩张，并成为门诊关节镜手术的主要中心，进一步推动了市场的成长。新兴经济体医疗基础设施的不断扩张，以及医疗支出的不断增长，正在推动关节镜技术和设备在公立和私人医疗机构的广泛应用。

电动刮鬍刀系统在微创关节手术中发挥精准组织和骨骼切除的关键作用，在2024年占据了23.9%的市场。其卓越的效率、便利的操作以及与先进视觉化系统无缝整合的能力，使其成为现代关节镜手术的首选工具。电动刮鬍刀系统在门诊手术中心的日益普及，有助于推动其普及，因为它们不仅缩短了手术时间，还提高了手术的精确度和成功率。

2024年，膝关节镜手术占了最大的市场份额，达到41.6%，这归因于全球膝关节相关损伤和骨关节炎病例的激增。该领域受益于体育运动参与度的提高、老龄人口的增加以及微创干预的广泛应用。韧带撕裂和软骨损伤通常使用关节镜方法治疗，使其成为最常用的手术方式。技术、工具和復健效果的改进继续巩固了其在已开发地区和发展中地区的主导地位。

2024年，北美关节镜器材市场占35.3%的市占率。这一领先地位得益于其先进的外科基础设施、尖端医疗技术的早期应用以及骨科手术的高频率。美国和加拿大持续投资专科骨科中心和门诊手术设施，从而实现了微创技术的大规模整合。预期寿命的延长，加上骨关节炎和运动伤害的发生率不断上升，进一步加速了该地区对关节镜器械的需求。

全球关节镜器材市场的主要参与者包括奥林巴斯、Medacta、施乐辉、美敦力、Hemodia、史赛克、理查德·沃夫、CONMED、Karl Storz、Arthrex、Invamed、Zimmer Biomet、B. Braun 和 DePuy Synthes (J&J)。关节镜器械市场的领先公司正在透过持续投资下一代手术技术来提升其地位。机器人技术、人工智慧驱动的可视化和一次性工具方面的创新正在帮助这些公司提供更高的精度、更短的恢復期和更好的临床结果。一些参与者正在扩展其门诊专用产品线，以满足门诊手术中心日益增长的需求。与医疗机构和运动医学专家的策略合作使公司能够开发适合不断发展的手术技术的专用器材。此外，许多公司正透过加强区域分销网路和推出具有成本效益的器械产品线来瞄准高成长的新兴市场。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 运动伤害和骨科疾病的发生率不断上升
    • 对微创外科手术的需求不断增长
    • 老年人口日益增多，易患关节疾病
    • 关节镜可视化和成像技术的进展
  • 产业陷阱与挑战
    • 关节镜设备和植入物成本高昂
    • 低收入和农村地区的交通不便
  • 市场机会
    • 与人工智慧和机器人辅助关节镜技术整合
    • 新兴市场的成长潜力
• 成长潜力分析
• 监管格局
• 技术和创新格局
  • 当前的技术趋势
  • 新兴技术
• 供应链分析
• 消费者行为趋势
• 市场进入策略分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析
• 2024年定价分析
• 专利态势
• 报销场景
  • 报销政策对市场成长的影响

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 全球的
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：依产品类型，2021 - 2034 年

• 主要趋势
• 电动刮鬍刀系统
• 可视化系统
• 关节镜
• 流体管理系统
• 关节镜植入物
• 射频（RF）消融系统
• 其他产品类型

第六章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 膝关节镜检查
• 肩关节镜检查
• 髋关节镜检查
• 其他应用

第七章：市场估计与预测：按可用性，2021 - 2034 年

• 主要趋势
• 可重复使用的关节镜
• 免洗关节镜

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Arthrex
• B. Braun
• CONMED
• DePuy Synthes (J&J)
• Hemodia
• Invamed
• Karl Storz
• Medacta
• Medtronic
• Olympus
• Richard Wolf
• Smith & Nephew
• Stryker
• Zimmer Biomet

The Global Arthroscopy Instruments Market was valued at USD 6.5 billion in 2024 and is estimated to grow at a CAGR of 3.9% to reach USD 9.4 billion by 2034. Rising rates of joint-related conditions, a growing elderly population, and increasing sports injuries are among the major forces driving this market. There is a growing shift toward minimally invasive procedures, and arthroscopy stands out as a preferred approach due to its benefits, such as shorter recovery times, reduced hospital stays, and lower post-operative complications. Additionally, advancements in visualization technologies, robotics integration, and a greater emphasis on disposable devices are transforming arthroscopy procedures. Increasing patient awareness about early treatment and diagnosis of joint issues is also helping to fuel demand for these instruments globally.

Ambulatory surgical centers, especially in urban settings, are rapidly expanding and becoming major hubs for outpatient arthroscopy, contributing further to market growth. Expanding healthcare infrastructure in emerging economies, alongside rising expenditure, is encouraging broader adoption of arthroscopic techniques and devices across both public and private health sectors.

The powered shaver systems captured a 23.9% share in 2024, owing to their essential role in delivering precise tissue and bone resection during minimally invasive joint procedures. Their superior efficiency, ease of handling, and ability to integrate seamlessly with advanced visualization systems make them a preferred tool in modern arthroscopic surgeries. Their growing use in outpatient surgical centers is helping fuel adoption, as they reduce operation time while enhancing precision and procedural success.

The knee arthroscopy segment held the largest market share at 41.6% in 2024, attributed to the high volume of knee-related injuries and osteoarthritis cases globally. The segment benefits from growing sports participation, a rise in elderly populations, and a broader shift toward minimally invasive interventions. Ligament tears and cartilage damage are routinely addressed using arthroscopic methods, making it the most performed procedure. Improvements in techniques, tools, and recovery outcomes continue to support its dominance across both developed and developing regions.

North America Arthroscopy Instruments Market held a 35.3% share in 2024. This leadership is driven by advanced surgical infrastructure, early adoption of cutting-edge medical technologies, and a high frequency of orthopedic procedures. The U.S. and Canada continue to invest in specialty orthopedic centers and outpatient surgical facilities, enabling wide-scale integration of minimally invasive techniques. Rising life expectancy, combined with the increasing prevalence of osteoarthritis and sports injuries, further accelerates the demand for arthroscopic tools across the region.

Key participants in the Global Arthroscopy Instruments Market include Olympus, Medacta, Smith & Nephew, Medtronic, Hemodia, Stryker, Richard Wolf, CONMED, Karl Storz, Arthrex, Invamed, Zimmer Biomet, B. Braun, and DePuy Synthes (J&J). Leading companies in the arthroscopy instruments market are advancing their position through consistent investment in next-generation surgical technologies. Innovations in robotics, AI-driven visualization, and disposable tools are helping these firms offer greater precision, shorter recovery periods, and enhanced clinical outcomes. Several players are expanding their outpatient-specific product lines to meet rising demand from ambulatory surgical centers. Strategic collaborations with healthcare institutions and sports medicine specialists are enabling companies to develop procedure-specific instruments tailored to evolving surgical techniques. Additionally, many are targeting high-growth emerging markets by strengthening regional distribution networks and launching cost-effective instrument lines.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 Usability trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of sports-related injuries and orthopedic disorders
    • 3.2.1.2 Growing demand for minimally invasive surgical procedures
    • 3.2.1.3 Increasing geriatric population prone to joint diseases
    • 3.2.1.4 Advancements in arthroscopic visualization and imaging technologies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of arthroscopy equipment and implants
    • 3.2.2.2 Limited accessibility in low-income and rural regions
  • 3.2.3 Market opportunities
    • 3.2.3.1 Technological integration with AI and robotic-assisted arthroscopy
    • 3.2.3.2 Growth potential in emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Consumer behaviour trend
• 3.8 Go-to-market strategy analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
• 3.12 Gap analysis
• 3.13 Pricing analysis, 2024
• 3.14 Patent Landscape
• 3.15 Reimbursement scenario
  • 3.15.1 Impact of reimbursement policies on market growth

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
  • 4.2.5 Latin America
  • 4.2.6 Middle East and Africa
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Powered shaver systems
• 5.3 Visualization systems
• 5.4 Arthroscopes
• 5.5 Fluid management systems
• 5.6 Arthroscopic implants
• 5.7 Radiofrequency (RF) ablation systems
• 5.8 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Knee arthroscopy
• 6.3 Shoulder arthroscopy
• 6.4 Hip arthroscopy
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Reusable arthroscope
• 7.3 Disposable arthroscopes

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Arthrex
• 10.2 B. Braun
• 10.3 CONMED
• 10.4 DePuy Synthes (J&J)
• 10.5 Hemodia
• 10.6 Invamed
• 10.7 Karl Storz
• 10.8 Medacta
• 10.9 Medtronic
• 10.10 Olympus
• 10.11 Richard Wolf
• 10.12 Smith & Nephew
• 10.13 Stryker
• 10.14 Zimmer Biomet